Checkpoint inhibitors are a groundbreaking class of cancer treatment, but they come with two frustrating challenges. In some cases, tumors show no initial response, rendering the therapy ineffective ...

Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.

Panelists discuss how overcoming resistance to EGFR TKIs requires next-generation inhibitors and more individualized treatment strategies. Panelists discuss how resistance to EGFR tyrosine kinase ...

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody linavonkibart demonstrated the ...

Resistance—the pushback we feel when facing change—isn’t a flaw; it’s data. It signals unmet needs, unprocessed fears, or a lack of clarity. Why do we hesitate, avoid, or resist what’s ahead? With ...

A team of researchers has developed gold nanoparticles (AuNPs) conjugated with trastuzumab as a possible cancer treatment. Published in Cancer Nanotechnology, the study focused on how these tiny ...

Please provide your email address to receive an email when new articles are posted on . More than 100 years ago, Ernest Amory Codman, MD, FACS, introduced his “end result idea.” Codman advocated that ...

In recent years, we’ve seen tremendous growth in diversity, equity, and inclusion initiatives. Many people have eagerly embraced these efforts, but some have criticized and resisted them, including ...